ClinicalTrials.govpublic full text
Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma
renal cell carcinoma, advanced, recurrent, refractory
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 474779
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.